198 related articles for article (PubMed ID: 17049414)
1. Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1.
Wang Z; La Rosa C; Li Z; Ly H; Krishnan A; Martinez J; Britt WJ; Diamond DJ
Vaccine; 2007 Jan; 25(6):1132-41. PubMed ID: 17049414
[TBL] [Abstract][Full Text] [Related]
2. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
[TBL] [Abstract][Full Text] [Related]
3. A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector.
Wang Z; Zhou W; Srivastava T; La Rosa C; Mandarino A; Forman SJ; Zaia JA; Britt WJ; Diamond DJ
Virology; 2008 Aug; 377(2):379-90. PubMed ID: 18538366
[TBL] [Abstract][Full Text] [Related]
4. MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adults.
La Rosa C; Longmate J; Martinez J; Zhou Q; Kaltcheva TI; Tsai W; Drake J; Carroll M; Wussow F; Chiuppesi F; Hardwick N; Dadwal S; Aldoss I; Nakamura R; Zaia JA; Diamond DJ
Blood; 2017 Jan; 129(1):114-125. PubMed ID: 27760761
[TBL] [Abstract][Full Text] [Related]
5. Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells.
Wang Z; La Rosa C; Mekhoubad S; Lacey SF; Villacres MC; Markel S; Longmate J; Ellenhorn JD; Siliciano RF; Buck C; Britt WJ; Diamond DJ
Blood; 2004 Aug; 104(3):847-56. PubMed ID: 15090456
[TBL] [Abstract][Full Text] [Related]
6. Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins.
Reap EA; Dryga SA; Morris J; Rivers B; Norberg PK; Olmsted RA; Chulay JD
Clin Vaccine Immunol; 2007 Jun; 14(6):748-55. PubMed ID: 17442845
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
[TBL] [Abstract][Full Text] [Related]
8. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
[TBL] [Abstract][Full Text] [Related]
9. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.
Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K
J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694
[TBL] [Abstract][Full Text] [Related]
10. A synthetic human cytomegalovirus pp65-IE1 fusion antigen efficiently induces and expands virus specific T cells.
Link EK; Brandmüller C; Suezer Y; Ameres S; Volz A; Moosmann A; Sutter G; Lehmann MH
Vaccine; 2017 Sep; 35(38):5131-5139. PubMed ID: 28818566
[TBL] [Abstract][Full Text] [Related]
11. Refinement in the production and purification of recombinant HCMV IE1-pp65 protein for the generation of epitope-specific T cell immunity.
Nguyen TH; Mifsud NA; Stewart LA; Rose MJ; Etto TL; Williamson NA; Purcell AW; Kotsimbos T; Schwarer AP
Protein Expr Purif; 2008 Sep; 61(1):22-30. PubMed ID: 18539483
[TBL] [Abstract][Full Text] [Related]
12. DNA and low titer, helper-free, recombinant AAV prime-boost vaccination for cytomegalovirus induces an immune response to CMV-pp65 and CMV-IE1 in transgenic HLA A*0201 mice.
Gallez-Hawkins G; Li X; Franck AE; Thao L; Lacey SF; Diamond DJ; Zaia JA
Vaccine; 2004 Dec; 23(6):819-26. PubMed ID: 15542207
[TBL] [Abstract][Full Text] [Related]
13. Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65).
Morello CS; Cranmer LD; Spector DH
J Virol; 2000 Apr; 74(8):3696-708. PubMed ID: 10729145
[TBL] [Abstract][Full Text] [Related]
14. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
[TBL] [Abstract][Full Text] [Related]
15. A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models.
Krishnan A; Wang Z; Srivastava T; Rawal R; Manchanda P; Diamond DJ; La Rosa C
Immunol Lett; 2008 Oct; 120(1-2):108-16. PubMed ID: 18706443
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants.
Gibson L; Dooley S; Trzmielina S; Somasundaran M; Fisher D; Revello MG; Luzuriaga K
J Infect Dis; 2007 Jun; 195(12):1789-98. PubMed ID: 17492595
[TBL] [Abstract][Full Text] [Related]
17. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.
Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG
J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876
[TBL] [Abstract][Full Text] [Related]
18. Functional comparison of T cells recognizing cytomegalovirus pp65 and intermediate-early antigen polypeptides in hematopoietic stem-cell transplant and solid organ transplant recipients.
Lacey SF; La Rosa C; Zhou W; Sharma MC; Martinez J; Krishnan A; Gallez-Hawkins G; Thao L; Longmate J; Spielberger R; Forman SJ; Limaye A; Zaia JA; Diamond DJ
J Infect Dis; 2006 Nov; 194(10):1410-21. PubMed ID: 17054071
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs.
Gyulai Z; Endresz V; Burian K; Pincus S; Toldy J; Cox WI; Meric C; Plotkin S; Gönczöl E; Berencsi K
J Infect Dis; 2000 May; 181(5):1537-46. PubMed ID: 10823751
[TBL] [Abstract][Full Text] [Related]
20. The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.
Lilja AE; Mason PW
Vaccine; 2012 Nov; 30(49):6980-90. PubMed ID: 23041121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]